Business
Novo Nordisk has published its annual report for 2025
Bagsværd, Denmark, 4 February 2026 – Today, Novo Nordisk A/S has issued its 2025 annual report. The report is available here: https://www.novonordisk.com/investors/annual-report.html and is attached in iXBRL format. Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines
About this update from Novo Nordisk A/s Class B
[{"type":"image","alt":"Novo Nordisk A/S","displaySize":"","headline":null,"caption":"Novo Nordisk A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":214,"url":"https://media.zenfs.com/en/globenewswire.com/b199128d4b2bbea4504ed4a2f3b29b4e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Sq36MpNFOiz.w6RiXrpsqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMwMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/b199128d4b2bbea4504ed4a2f3b29b4e","width":300,"height":214}},"lazy":false},{"type":"text","content":"Bagsværd, Denmark, 4 February 2026 – Today, Novo Nordisk A/S has issued its 2025 annual report.","length":100,"tagName":"p"},{"type":"text","content":"The report is available here: https://www.novonordisk.com/investors/annual-report.html and is attached in iXBRL format.","length":124,"tagName":"p"},{"type":"text","content":"Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.","length":661,"tagName":"p"},{"type":"text","content":"Contacts for further information:","length":33,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:217.54px;vertical-align:top;","val":[{"type":"text","content":"Novo Nordisk Media:","length":19,"tagName":"p","attribs":{}}]},{"style":"width:217.47px;vertical-align:top;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:217.54px;vertical-align:top;","val":[{"type":"text","content":"Ambre James-Brown+45 3079 [email protected] ","length":59,"tagName":"p","attribs":{}}]},{"style":"width:217.47px;vertical-align:top;","val":[{"type":"text","content":"Liz Skrbkova (US)+1 609 917 [email protected]","length":54,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:217.54px;vertical-a...